Area Development
Monitored Therapeutics, Inc., an emerging best-in-class remote patient management company, plans to expand its facility in Dublin, Ohio. The $650,000 project is expected to create 35 new jobs.

The company plans to relocate to a new 17,000-square-foot building at 5160 Blazer Parkway. MTI recently received a new round of venture capital funding from Tamarind Hill, and this larger facility will allow the company to better serve its market and improve delivery times.

“This project will expand our small and very mobile team while growing deep roots and our commitment to the Dublin community,” said Michael Taylor, Monitored Therapeutics CEO. “We’ve experienced significant growth and success over the past year and a half, and the MTI team is looking forward to building upon that from our strategic location in Central Ohio.”

Founded in 2011 in Dublin, MTI is a Remote Patient Monitoring company specializing in respiratory diseases including COPD, Asthma, Cystic Fibrosis, as well as Lung Transplant. MTI provides patients with access to care through its technology platform, increasing patient engagement, drug adherence and quality of life while decreasing overall healthcare costs by keeping patients in their homes and out of the hospital.

“MTI is an Ohio-headquartered company that continues to grow its remote patient monitoring operations with the advantage of Ohio’s talent, ingenuity and location,” said J.P. Nauseef, president and CEO of JobsOhio. “This expansion demonstrates MTI’s ongoing confidence in the Columbus Region as it continues to evolve the rapidly emerging health tech sector.”

“By increasing its workforce from seven to 35 employees, MTI will play a vital role in bringing high-quality jobs and skilled workers to Dublin,” said Jenna Goehring, City of Dublin economic development administrator. “The city is proud to have innovative healthcare companies, including MTI, grow and thrive, developing technologies that have a global impact.”